PCV48 ASSESSMENT OF MAXIMUM LDL-C REDUCTION AND GOAL ATTAINMENT BY SWITCHING PATIENTS TO DUAL INHIBITION THERAPY (EZETIMIBE/SIMVASTATIN) IN SPAIN

✍ Scribed by G Davies; G Nocea; E Alemao; D Yin; J Cook

• Book ID: 118607729
• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 62 KB
• Volume: 8
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)67459-1